DTL
RVMD icon

Dynamic Technology Lab’s Revolution Medicines RVMD Stock Holding History

Dynamic Technology Lab’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,762
Closed -$801K – 1161
2025
Q2 		$801K Buy
21,762
+7,574
+53% +$291K 0.11% 332
2025
Q1 		$502K Buy
+14,188
New +$576K 0.07% 479
2024
Q2 		– Sell
-8,320
Closed -$268K – 1320
2024
Q1 		$268K Buy
+8,320
New +$247K 0.03% 816
2023
Q4 		– Sell
-25,208
Closed -$698K – 1348
2023
Q3 		$698K Buy
+25,208
New +$748K 0.07% 378
2022
Q3 		– Sell
-10,572
Closed -$206K – 1465
2022
Q2 		$206K Buy
+10,572
New +$206K 0.02% 906
2022
Q1 		– Sell
-8,944
Closed -$225K – 1451
2021
Q4 		$225K Sell
8,944
-8,046
-47% -$227K 0.02% 917
2021
Q3 		$468K Buy
+16,990
New +$495K 0.06% 554

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Dynamic Technology Lab's RVMD Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 21,762 shares — an estimated $801K sold.

Dynamic Technology Lab first reported a position in RVMD in Q3 2021 and held it in 7 quarters. The position peaked at $801K in Q2 2025. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Dynamic Technology Lab reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 21,762 Revolution Medicines shares in Q3 2025, an estimated $801K.
  • Dynamic Technology Lab first reported a position in Revolution Medicines in Q3 2021 and held it in 7 quarters.
  • Dynamic Technology Lab's Revolution Medicines position peaked at $801K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.